Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2010-03-03 06:00:00

ROCHESTER, N.Y. and SOPHIA ANTIPOLIS, France, March 3 /PRNewswire/ -- NicOx S.A. (NYSE Euronext Paris: COX) and Bausch + Lomb, a leading eye health company, today announced the companies have entered into a licensing agreement which grants Bausch + Lomb exclusive worldwide rights to develop and commercialize NCX 116 (previously PF-03187207), a nitric oxide-donating prostaglandin F2-alpha analog. Eye disease affects millions of people worldwide and can lead to impaired vision or total...

2010-03-02 11:20:00

NASHVILLE, Tenn., March 2 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the safety and efficacy of Caldolor® (ibuprofen) Injection in treating pain and fever in hospitalized burn patients will be presented at the 42nd Annual Meeting of the American Burn Association in Boston. The new data will be displayed in a poster presentation on Wednesday, March 10, from 12:15 p.m. to 1:15 p.m. ET....

2eaf3cb41c1cf885cd82249d8fceceb9
2010-03-01 09:15:00

According to new study published in the American Journal of Medicine In a study published in the March 2010 issue of The American Journal of Medicine, researchers determined that regular use of aspirin, acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) increases the risk of hearing loss in men, particularly in younger men, below age 60. Hearing loss is the most common sensory disorder in the US, afflicting over 36 million people. Not only is hearing loss highly prevalent among...

b52133595a61a132ef5f269808b3bf431
2010-02-18 09:12:36

New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson's disease, according to a study released this week that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010. The research involved 136,474 people who did not have Parkinson's disease at the beginning of the research. Participants were asked about their use of non-steroid anti-inflammatory drugs (NSAIDs), including aspirin,...

2010-02-17 16:07:00

ST. PAUL, Minn., Feb. 17 /PRNewswire-USNewswire/ -- New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010. The research involved 136,474 people who did not have Parkinson's disease at the beginning of the research. Participants were asked about their use of non-steroid...

2010-02-16 08:09:06

Contrary to previous hypotheses, the use of non-steroidal anti-inflammatory drugs does not appear associated with risk of squamous cell skin cancer, according to a report posted online today that will appear in the April print issue of Archives of Dermatology, one of the JAMA/Archives journals. Non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen and celecoxib reduce pain and inflammation by blocking an enzyme involved in producing inflammatory compounds, according to...

2010-02-04 05:02:00

SAN ANTONIO, Feb. 4 /PRNewswire-USNewswire/ -- Tanezumab, a humanized monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions, according to the results from three phase two studies presented today in a single poster at the American Academy of Pain Medicine's 26th Annual Meeting. Researchers from Pfizer presented the results from three separate randomized, double-blind, placebo-controlled, clinical trials of tanezumab involving a total of 725...

2010-01-20 13:47:10

Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen may be more effective for relieving period pain than paracetamol, according to the update of a Cochrane Review. However, it remains unclear whether any one NSAID is safer or more effective than others. Period pain affects a high proportion of women: up to 72% in a recent Australian survey of 16-49 year olds. It is thought to be caused by an excess or imbalance of certain hormones released by the body during menstrual periods,...

2010-01-20 10:32:00

NASHVILLE, Tenn., Jan. 20 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) has donated 15,000 vials of Caldolor® (ibuprofen) Injection, an intravenous form of ibuprofen, to Haitian relief effort. Caldolor is the first and only injectable product approved for the treatment of pain and reduction of fever in the United States. As health conditions in Haiti continue to deteriorate, Caldolor is expected to help those suffering from fever as a result...

2010-01-05 13:48:00

NASHVILLE, Tenn., Jan. 5 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that data from clinical trials for Caldolor® (ibuprofen) Injection, an intravenous formulation of ibuprofen approved to treat pain and fever in adults, will be presented at a Breakfast Satellite Symposium on Tuesday, January 12, 2010 from 6:30 to 8:00 am ET. The symposium, entitled "New Advances in the Management of Pain and Fever in the Hospital Setting,"...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.